Dry Needling for Cervicogenic Headache

May 18, 2020 updated by: Kathleen Geist, Emory University

Comparison of Dry Needling Versus Upper Extremity Strengthening and Dry Needling for Individuals With Cervicogenic Headache

This is a single-blinded randomized clinical trial. The primary aim of this study is to compare the effectiveness of dry needling of myofascial trigger points in the muscles of the head and cervical spine in addition to an upper extremity strengthening/stretching exercise program compared to a dry needling group alone on pain scores, cervical range of motion, pain sensitivity and changes in severity and frequency of pain symptoms in individuals with cervicogenic headache.

Study Overview

Detailed Description

This is a single-blinded randomized clinical trial. Eligible participants who agree to enroll in the study will be asked to attend four testing sessions. Participants in both groups will receive dry needling to the involved head and cervical muscles and the other group, in addition to receiving a dry needling intervention, will be instructed in a standard home exercise program consisting of strengthening and stretching exercises for the upper quarter. All dry needling (using standard clean technique) will be performed by licensed physical therapists board certified in orthopaedic physical therapy and having a minimum of 5 years of experience treating patient populations with dry needling.

The aim of this research study is to compare he effectiveness of dry needling alone with dry needling and a home exercise program on pain, pain sensitivity, cervical range of motion, and changes in the severity and frequency among individuals with headache symptoms.

Study Type

Interventional

Enrollment (Actual)

7

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Georgia
      • Atlanta, Georgia, United States, 30322
        • Emory University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Unilateral headache (HA) without side shift
  • H/o pain triggered by neck movement
  • Limitation in cervical range of motion
  • Ispilateral neck, shoulder or arm pain
  • Intermittent pain with episodes varying in duration
  • Head and neck pain is non-throbbing in nature

Exclusion Criteria:

  • Use of anti-coagulation medicine (except low dose aspirin)
  • Pregnancy
  • Acute or uncontrolled medical illness
  • Opioid use within six months
  • Fibromyalgia or diffuse painful syndromes in the UE or LE
  • Substance abuse
  • Presence of fever, vomiting or visual changes

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Dry needling and upper extremity stretching program Arm

Participants will receive a combination of dry needling and upper extremity stretching.

  • Dry needling in regions of the head and cervical spine will be positioned supine, sidelying or prone with the relevant myofascial trigger points treated using a Seirin L- type 30 mm needle (Seirin America, Inc., Weymouth, MA). The needle will be inserted to a depth no greater than three-quarters length of the needle for 30 seconds using a vertical pistoning technique and then statically up to 5 minutes.
  • A standard home exercise program consisting of strengthening and stretching exercises for the upper quarter.
Dry Needling is a treatment technique whereby a sterile, single-use, fine filament needle is inserted into the muscle to assist with decreasing pain and improving function through the release of myofascial trigger points (knots in the muscle).
Other Names:
  • Myofascial trigger point dry needling
  • Intramuscular stimulation
A standard home exercise program consisting of strengthening and stretching exercises for the upper quarter
Active Comparator: Dry Needling Arm
Dry needling in regions of the head and cervical spine will be positioned supine, sidelying or prone with the relevant myofascial trigger points treated using a Seirin L- type 30 mm needle (Seirin American, Inc., Weymouth, MA). The needle will be inserted to a depth no greater than three-quarters length of the needle for 30 seconds using a vertical pistoning technique and then statically up to 5 minutes.
Dry Needling is a treatment technique whereby a sterile, single-use, fine filament needle is inserted into the muscle to assist with decreasing pain and improving function through the release of myofascial trigger points (knots in the muscle).
Other Names:
  • Myofascial trigger point dry needling
  • Intramuscular stimulation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in visual analog score for pain level
Time Frame: Baseline, Weeks 1 to 4 post intervention
Pain is reported using a Visual Analog Scale from 0-10 and evaluates the frequency, severity and duration of the pain. Higher score indicates worse outcome.
Baseline, Weeks 1 to 4 post intervention
Change in pain pressure threshold (PPT)
Time Frame: Baseline, Weeks 1 to 4 post intervention
Pressure algometry is a method described to determine pressure pain threshold (PPT) by applying controlled pressure to a given body point. Measured with a pressure algometer: 0-50 KPa/s (kilopascal/second squared), minimum score representing increased pain to light touch/measuring allodynia.
Baseline, Weeks 1 to 4 post intervention
Change in cervical range of motion
Time Frame: Baseline, Weeks 1 to 4 post intervention
Will measure C1-2 Active Range of Motion, min score, 0; max score 50 degrees, lower score more limited (worse outcome).
Baseline, Weeks 1 to 4 post intervention
Functional outcome measure: Change in neck disability index
Time Frame: Baseline, Weeks 1 to 4 post intervention
Score ranges from 0-50 points: higher scores indicate higher levels of disability; Minimal detectable change (MDC), 5 points.
Baseline, Weeks 1 to 4 post intervention
Functional outcome measure: Change in headache disability index
Time Frame: Baseline, Weeks 1 to 4 post intervention
Score ranges from 0-72: 0 is no disability, 72 is more severe disability. Minimally Clinically Important Difference (MCID) is 29 points.
Baseline, Weeks 1 to 4 post intervention
Change in Pain Frequency-Severity-Duration (PFDS) Scale
Time Frame: Baseline, Weeks 1 to 4 post intervention

PFSD scale ranges from 1-140 with higher scores indicative of higher disability.

There is a composite score that ranges from 0-140. Higher score correlates with worse outcome.

Baseline, Weeks 1 to 4 post intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kathleen Geist, PT, DPT, Emory University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 12, 2020

Primary Completion (Actual)

April 1, 2020

Study Completion (Actual)

April 1, 2020

Study Registration Dates

First Submitted

March 10, 2020

First Submitted That Met QC Criteria

March 10, 2020

First Posted (Actual)

March 12, 2020

Study Record Updates

Last Update Posted (Actual)

May 19, 2020

Last Update Submitted That Met QC Criteria

May 18, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Headache

Clinical Trials on Dry Needling

3
Subscribe